Comments

Atossa Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Atossa Therapeutics (ATOS) operate in?

Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ATOSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.7538

0.045.35%

At close: -

$0.7500

-0.00380-0.50%

After Hours: Mar 21, 6:12 PM EDT

Q4 2024 earnings tomorrow on Tue Mar 25th before the market open

Conference call scheduled tomorrow at 8:30 AM Click to view the webcast

Atossa Therapeutics (ATOS) Forecast

News Earnings Atossa Therapeutics (ATOS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Atossa Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ATOS | Benzinga

Explore Atossa Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ATOS.

Open	$0.71
Close	$0.75
Volume / Avg.	1.06M / 685.46K
Day Range	$0.71 - $0.75
52 Wk Range	0.66 - 2.31
Market Cap	$94.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	7.05%
Days to Cover	16.92

Recent News

Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.71
Close	$0.75
Volume / Avg.	1.06M / 685.46K
Day Range	$0.71 - $0.75
52 Wk Range	0.66 - 2.31
Market Cap	$94.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	7.05%
Days to Cover	16.92

About Atossa Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovat...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Atossa Therapeutics (ATOS) stock?

You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.

View our list of the best stock brokerages

Who are Atossa Therapeutics (ATOS) competitors?

Other companies in Atossa Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Cabaletta Bio (NASDAQ:CABA), Galectin Therapeutics (NASDAQ:GALT), OncoCyte (NASDAQ:OCX) and Whitehawk Therapeutics (NASDAQ:WHWK).

What is the forecast, or price target, for Atossa Therapeutics (ATOS) stock?

Atossa Therapeutics has a consensus price target of $7.00.

What is the current price for Atossa Therapeutics (ATOS)?

The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $0.75 last updated March 21, 2025 at 6:12 PM EDT.

Does Atossa Therapeutics (ATOS) pay a dividend?

There are no upcoming dividends for Atossa Therapeutics.

When is Atossa Therapeutics (NASDAQ:ATOS) reporting earnings?

Atossa Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Atossa Therapeutics (ATOS) going to split?

There is no upcoming split for Atossa Therapeutics.

What sector and industry does Atossa Therapeutics (ATOS) operate in?

Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.